Related Experiment Video
Updated: Mar 25, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
Published on: June 18, 2020
Diastolic Dysfunction in Liver Cirrhosis: Prognostic Predictor in Liver Transplantation?
F Carvalheiro1, C Rodrigues2, T Adrego3
1Department of Anesthesia, Centro Hospitalar do Algarve, Portimão, Portugal.
Diastolic dysfunction (DD) is common in liver cirrhosis patients before liver transplantation (LT). This cardiac condition, along with a prolonged QTc interval, can increase mortality risk after LT.
Area of Science:
- Cardiology
- Hepatology
- Transplantation Medicine
Background:
- Liver cirrhosis can lead to cirrhotic cardiomyopathy (CC).
- CC is marked by impaired contractile response to stress, diastolic dysfunction (DD), and electrical abnormalities.
- These cardiac issues can negatively impact patient prognosis.
Purpose of the Study:
- To analyze the prevalence of diastolic dysfunction (DD) and prolonged QTc interval in patients with liver cirrhosis awaiting liver transplantation (LT).
- To investigate the correlation between these cardiac abnormalities and post-LT outcomes, including mortality.
Main Methods:
- Retrospective analysis of 106 patients undergoing LT between January 2012 and June 2015.
- Evaluation of demographic data, cirrhosis etiology, Child-Pugh and MELD scores, preoperative QTc interval, and cardiac function (systolic and diastolic).
- Statistical comparison of DD and QTc prolongation with MELD/Child-Pugh scores and post-LT outcomes using chi-square, Fisher, and Mann-Whitney U tests.
Main Results:
- The study included 106 patients (80.2% male, average age 54.83 years).
- Prevalence of prolonged QTc was 19% and DD was 35.8%.
- No significant association was found between QTc prolongation or DD and MELD or Child-Pugh scores.
Conclusions:
- A significant incidence of diastolic dysfunction (DD) was observed in patients pre-LT, indicating a predisposition to adverse cardiac events.
- The presence of DD is associated with increased mortality following liver transplantation in patients with hepatic cirrhosis.
More Related Videos
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):

